Isolated cardiac sarcoidosis: a case report

Introduction. Ventricular arrhythmias are a risk factor for sudden cardiac death. Abnormalities of cardiac rhythm and conduction may be the only subjective manifestation of isolated cardiac sarcoidosis, which occurs in 25% of the total number of patients with this disease.

Brief description. We present a case of isolated cardiac sarcoidosis in a young female patient, the main clinical manifestation of which was attacks of palpitations caused by ventricular tachycardia and episodes of cardiogenic shock without a cardiovascular history. Echocardiography and contrast-enhanced cardiac magnetic resonance imaging (MRI) revealed asymmetric left ventricular hypertrophy and focal myocardial masses. Cardiac tumor and sarcoidosis were suspected. The final diagnosis was based on the results of histological and immunohistochemical analysis of endomyocardial biopsies documenting sarcoidosis. No systemic manifestations of sarcoidosis were found.

Discussion. The case demonstrates the potential of a comprehensive paraclinical study in the diagnosis of cardiac sarcoidosis and its differential diagnosis with other cardiac pathologies.

Conclusion. Cardiac sarcoidosis is difficult to diagnose and requires histological verification in patients with LV hypertrophy and arrhythmias, and physicians should be aware about this rare disease with unfavorable prognosis without specific treatment.

1. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. doi:10.1093/eurheartj/ehac262.

2. Lebedev DS, Mikhailov EN, Neminuschiy NM, et al. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Russian Journal of Cardiology. 2021;26(7):4600. (In Russ.) doi:10.15829/1560-4071-2021-4600.

3. Lemay S, Massot M, Philippon F, et al. Ten questions cardiologists should be able to answer about cardiac sarcoidosis: case-based approach and contemporary review. CJC Open. 2020;3(4):532-48. doi:10.1016/j.cjco.2020.11.022.

4. Trisvetova EL, Yudina OA, Smolensky AZ, et al. Diagnosis of isolated cardiac sarcoidosis. Arkhiv patologii. 2019;81(1):57-64. (In Russ.) doi:10.17116/patol20198101157.

5. Kupari M, Lehtonen J.Point: should isolated cardiac sarcoidosis be considered a significant manifestation of sarcoidosis? Yes. Chest. 2021;160(1):36-8. doi:10.1016/j.chest.2020.12.037.

6. Moiseeva OM, Mikhailov EN, Mitrofanova LB, et al. Isolated sarcoidosis of the heart: clinical case and literary review. Russian Journal of Cardiology. 2016;(1):99-104. (In Russ.) doi:10.15829/1560-4071-2016-1-99-104.

7. Serova MV, Poltavskaya MG, Garmash YuYu, et al. Complete atrioventricular block as a clinical manifestation of cardiac sarcoidosis. Russian Journal of Cardiology. 2019;(11):63-8. (In Russ.) doi:10.15829/1560-4071-2019-11-63-68.

8. Terasaki F, Azuma A, Anzai T, et al. JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis — digest version. Circ J. 2019;83(11):2329-88. doi:10.1253/circj.CJ-19-0508.

9. Lehtonen J, Uusitalo V, Pöyhönen P, et al. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J. 2023;44(17):1495-510. doi:10.1093/eurheartj/ehad067.

10. Evlampieva LG, Yaroslavskaya EI. Sarcoidosis in Actual Clinical Practice. Siberian Medical Journal. 2018;33(3):17-21. (In Russ.) doi:10.29001/2073-8552-2018-33-3-17-21.

11. Terasaki F, Kuwabara H, Takeda Y, et al. Clinical features and histopathology of cardiac sarcoidosis with refractory heart failure: an autopsy case. Intern Med. 2019;58(24):3551- 5. doi:10.2169/internalmedicine.3147-19.

12. Nagai T, Nagano N, Sugano Y, et al. Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis. Circ J. 2015;79(7):1593-600. doi:10.1253/circj.CJ-14-1275.